These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37008338)

  • 41. Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis.
    Yang YX; Liu Y; Li CP; Lu PJ; Wang J; Gao J
    J Interv Cardiol; 2020; 2020():8179849. PubMed ID: 32684867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Coronary Artery Tortuosity on Outcomes Following Stenting: A Pooled Analysis From 6 Trials.
    Konigstein M; Ben-Yehuda O; Redfors B; Mintz GS; Madhavan MV; Golomb M; McAndrew T; Zhang Z; Kandzari DE; Hermiller JB; Leon MB; Stone GW
    JACC Cardiovasc Interv; 2021 May; 14(9):1009-1018. PubMed ID: 33640388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Cilostazol-Based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation: An Updated Meta-Analysis of the Randomized Controlled Trials.
    Zhao S; Zhong Z; Qi G; Shi L; Tian W
    Clin Drug Investig; 2019 Jan; 39(1):1-13. PubMed ID: 30251232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and Safety of Very Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Zhong PY; Shang YS; Bai N; Ma Y; Niu Y; Wang ZL
    Front Cardiovasc Med; 2021; 8():660360. PubMed ID: 34557526
    [No Abstract]   [Full Text] [Related]  

  • 45. Nine-month results of the BIOHELIX-I clinical trial study: Evaluation of the PRO-Kinetic Energy cobalt chromium bare-metal stent system.
    Michael TT; Richardt G; Lansky A; Carney RJ; Khan MA; Shehadeh A; Zeymer U; Gupta S
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1030-1039. PubMed ID: 29271575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug-Coated Balloon vs. Stent for
    Sun K; Liu Z; Wang H
    Front Cardiovasc Med; 2021; 8():700235. PubMed ID: 34957227
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug-coated balloon versus drug-eluting stent in de novo small coronary vessel disease: A systematic review and meta-analysis.
    Li M; Guo C; Lv YH; Zhang MB; Wang ZL
    Medicine (Baltimore); 2019 May; 98(21):e15622. PubMed ID: 31124941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Valgimigli M; Frati G; Kedhi E; Smits PC; Kaiser C; Genereux P; Galatius S; Kirtane AJ; Stone GW
    J Am Coll Cardiol; 2013 Aug; 62(6):496-504. PubMed ID: 23747778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes of Patients Treated with the Everolimus- versus the Paclitaxel-Eluting Stents in a Consecutive Cohort of Patients at a Tertiary Medical Center.
    Shammas NW; Shammas GA; Nader E; Jerin M; Mrad L; Ehrecke N; Shammas WJ; Voelliger CM; Hafez A; Kelly R; Reynolds E
    Int J Angiol; 2013 Sep; 22(3):165-70. PubMed ID: 24436605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and effectiveness of the Genous™ endothelial progenitor cell-capture stent in the first year following ST-elevation acute myocardial infarction: A single center experience and review of the literature.
    Pereira-da-Silva T; Bernardes L; Cacela D; Fiarresga A; Sousa L; Patrício L; Ferreira RC
    Cardiovasc Revasc Med; 2013; 14(6):338-42. PubMed ID: 24216000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Sanz Sánchez J; Chiarito M; Cortese B; Moretti A; Pagnotta P; Reimers B; Stefanini GG; Ferrante G
    Catheter Cardiovasc Interv; 2021 Jul; 98(1):66-75. PubMed ID: 32592437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First report on long-term clinical results after treatment of coronary bifurcation lesions with the Tryton dedicated bifurcation stent.
    Grundeken MJ; Kraak RP; Baan J; Arkenbout EK; Piek JJ; Vis MM; Henriques JP; Koch KT; Tijssen JG; de Winter RJ; Wykrzykowska JJ
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):759-65. PubMed ID: 25485348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis.
    Crimi G; Gritti V; Galiffa VA; Scotti V; Leonardi S; Ferrario M; Ferlini M; De Ferrari GM; Oltrona Visconti L; Klersy C
    J Interv Cardiol; 2018 Jun; 31(3):319-329. PubMed ID: 29285790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modified double-stent strategy may be an optimal choice for coronary bifurcation lesions: A systematic review and meta-analysis.
    Lv YH; Guo C; Li M; Zhang MB; Wang ZL
    Medicine (Baltimore); 2018 Nov; 97(48):e13377. PubMed ID: 30508932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry.
    Tamburino C; Capodanno D; Di Salvo ME; Sanfilippo A; Cascone I; Incardona V; Longo G; Giacoppo D; Capranzano P; Sgroi C; Ussia G; Monaco A; La Manna A
    EuroIntervention; 2012 Jan; 7(9):1062-8. PubMed ID: 22207230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Everolimus Eluting Stents in Patients with Diabetes Mellitus and Chronic Kidney Disease: Insights from the TUXEDO Trial.
    Bangalore S; Abhaichand R; Mullasari A; Jain R; Chand RKP; Arambam P; Kaul U
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1075-1080. PubMed ID: 31036397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial.
    Meredith IT; Worthley SG; Whitbourn R; Walters D; McClean D; Ormiston J; Horrigan M; Wilkins GT; Hendriks R; Matsis P; Muller D; Cutlip DE
    EuroIntervention; 2010 Jan; 5(6):692-7. PubMed ID: 20142220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical outcomes after percutaneous coronary intervention for early versus late and very late stent thrombosis: a systematic review and meta-analysis.
    Yang YX; Liu Y; Li XW; Lu PJ; Wang J; Li CP; Gao J
    J Thromb Thrombolysis; 2021 Apr; 51(3):682-692. PubMed ID: 32691275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective multi-center registry to evaluate efficacy and safety of the newly developed diamond-like carbon-coated cobalt-chromium coronary stent system.
    Ando K; Ishii K; Tada E; Kataoka K; Hirohata A; Goto K; Kobayashi K; Tsutsui H; Nakahama M; Nakashima H; Uchikawa S; Kanda J; Yasuda S; Yajima J; Kitabayashi H; Sakurai S; Nakanishi K; Inoue N; Noike H; Hasebe T; Sato T; Yamasaki M; Kimura T
    Cardiovasc Interv Ther; 2017 Jul; 32(3):225-232. PubMed ID: 27448025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy of everolimus-eluting stent implantation in patients with ST-segment elevation myocardial infarction: outcomes of 2-year clinical follow-up.
    Yano H; Horinaka S; Ishikawa M; Ishimitsu T
    Heart Vessels; 2016 Oct; 31(10):1609-15. PubMed ID: 26686370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.